January 9, 2017 / 1:28 PM / 6 months ago

BRIEF-Amag Pharmaceuticals sees Q4 2016 revenue $150 mln to $155 mln

1 Min Read

Jan 9 (Reuters) - AMAG Pharmaceuticals Inc :

* AMAG Pharmaceuticals provides financial and business update

* Sees Q4 2016 revenue $150 million to $155 million

* Sees FY 2016 revenue $546 million to $551 million

* Sees FY 2017 revenue $620 million to $670 million

* Expects 2016 total GAAP revenue to be between $529 million and $534 million

* AMAG Pharmaceuticals Inc sees FY 2017 total non-gaap revenue $625 million - $675 million

* FY2016 revenue view $551.3 million -- Thomson Reuters I/B/E/S

* FY2017 revenue view $636.5 million -- Thomson Reuters I/B/E/S

* AMAG Pharmaceuticals Inc sees FY 2017 net income in range of $19 - $60 million Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below